These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2784225)

  • 1. Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma.
    Pilarski LM; Andrews EJ; Serra HM; Ruether BA; Mant MJ
    Scand J Immunol; 1989 Feb; 29(2):217-28. PubMed ID: 2784225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function.
    Pilarski LM; Andrews EJ; Mant MJ; Ruether BA
    J Clin Immunol; 1986 Nov; 6(6):491-501. PubMed ID: 3023434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS).
    Büchi G; Girotto M; Termine G; Gario S; Grosso E; Autino R; Zappalà C
    Pathologica; 1985; 77(1050):385-93. PubMed ID: 3879633
    [No Abstract]   [Full Text] [Related]  

  • 5. Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Shapira R; Froom P; Kinarty A; Aghai E; Lahat N
    Br J Haematol; 1989 Feb; 71(2):223-5. PubMed ID: 2522313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity repertoire of lymphocytes from multiple myeloma patients. I. High frequency of B cells specific for idiotypic and F(ab')2-region determinants on immunoglobulin.
    Pilarski LM; Piotrowska-Krezolak M; Gibney DJ; Winger L; Winger C; Mant MJ; Ruether BA
    J Clin Immunol; 1985 Jul; 5(4):275-84. PubMed ID: 2995434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Miguel-Garcia A; Matutes E; Tarin F; Garcia-Talavera J; Miguel-Sosa A; Carbonell F; Catovsky D
    J Clin Pathol; 1995 Sep; 48(9):835-9. PubMed ID: 7490317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients.
    Serra HM; Mant MJ; Ruether BA; Ledbetter JA; Pilarski LM
    J Clin Immunol; 1988 Jul; 8(4):259-65. PubMed ID: 2970472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of immunoglobulin light chain isotype in B lymphocytes from patients with monoclonal gammopathies: isotypic discordance and clonal B-cell excess.
    Oritani K; Katagiri S; Tominaga N; Iida M; Amano T; Karasuno T; Matsumura I; Mitsui H; Kanayama Y; Yonezawa T
    Br J Haematol; 1990 May; 75(1):10-5. PubMed ID: 2115808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
    Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
    J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour load.
    Bergenbrant S; Osterborg A; Holm G; Mellstedt H; Lefvert AK
    Br J Haematol; 1991 May; 78(1):66-70. PubMed ID: 2043484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic B lymphocytes in patients with monoclonal gammopathies.
    Bergenbrant S; Yi Q; Osby E; Osterborg A; Ostman R; Björkholm M; Holm G; Lefvert AK
    Scand J Immunol; 1994 Aug; 40(2):216-20. PubMed ID: 8047844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
    Goodyear OC; Pratt G; McLarnon A; Cook M; Piper K; Moss P
    Blood; 2008 Oct; 112(8):3362-72. PubMed ID: 18658027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the pathogenesis of an immune defect in multiple myeloma.
    Paglieroni T; MacKenzie MR
    J Clin Invest; 1977 Jun; 59(6):1120-33. PubMed ID: 16939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
    Jensen GS; Mant MJ; Belch AJ; Berenson JR; Ruether BA; Pilarski LM
    Blood; 1991 Aug; 78(3):711-9. PubMed ID: 1830500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
    Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of T cell clones binding F(ab')2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy.
    Osterborg A; Masucci M; Bergenbrant S; Holm G; Lefvert AK; Mellstedt H
    Cancer Immunol Immunother; 1991; 34(3):157-62. PubMed ID: 1756532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies.
    Massaia M; Dianzani U; Bianchi A; Camponi A; Boccadoro M; Pileri A
    Clin Exp Immunol; 1988 Aug; 73(2):214-8. PubMed ID: 3263229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Almeida J; Orfao A; Mateo G; Ocqueteau M; García-Sanz R; Moro MJ; Hernandez J; Ortega F; Borrego D; Barez A; Mejido M; San Miguel JF
    Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.